About PRECOS
PRECOS is a Healthcare company based in United Kingdom founded in 2010, and was acquired by Crown Bioscience in July 2013. Preclinical oncology services with xenograft and metastatic models are provided. The company has 8 employees. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Oncology. Its legal entity is PROWEB (UK) LIMITED.
Company details
PRECOS was founded in 2010 in the United Kingdom, focusing on the oncology drug development sector. Preclinical services, including patient-derived xenograft, orthotopic, and metastatic modeling along with imaging, were delivered. Models that mirrored cancer progression stagessuch as pre-cancerous lesions, primary tumors, and metastasiswere employed to support research. Acquisition by Crown Bioscience occurred in 2013.
- Headquarters United Kingdom
- Employees 8
- Stage Acquired
- SectorsHealthcare
- Website precos.co.uk
- Social LinkedIn
- Acquired by Crown Bioscience (Jul 2013)
- Legal Name Proweb (Uk) Limited
- Date of Incorporation 21 Feb, 1996
- Jurisdiction NOTTINGHAM
- Investors
- Employee Count8
- Acquired byCrown Bioscience
(Jul 2013)
Investors in PRECOS
PRECOS has secured backing from 1 investor. Prominent investors backing the company include Crown Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cancer and CVMD drugs are developed using PDX models. | 2006 | crownbio.com | Santa Clara, United States |
Investor details for PRECOS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PRECOS
2 dated milestones of PRECOS across 3 years, from founding to its latest funding, stage changes and deals.
- Founded PRECOS is founded.
- Exit Acquired by Crown Bioscience.
Web traffic of PRECOS
Websites that share an audience with PRECOS (precos.co.uk).
Websites whose visitors overlap most with PRECOS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| crownbio.com | 100% | 77K | #441,040 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PRECOS
PRECOS was founded in 2010.
PRECOS is headquartered in United Kingdom.
PRECOS has 8 employees.
PRECOS was founded in 2010 in the United Kingdom, focusing on the oncology drug development sector. Preclinical services, including patient-derived xenograft, orthotopic, and metastatic modeling along with imaging, were delivered. Models that mirrored cancer progression stagessuch as pre-cancerous lesions, primary tumors, and metastasiswere employed to support research. Acquisition by Crown Bioscience occurred in 2013.
PRECOS has 1 investor. Key investors include Crown Bioscience.
PRECOS operates through Proweb (Uk) Limited.
Yes. PRECOS was acquired by Crown Bioscience in July 2013.